Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Insys Therapeutics Inc (INSY)

Insys Therapeutics Inc (INSY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Insys Therapeutics Inc 1333 S. Spectrum Blvd Suite 100 Chandler AZ 85286 USA

www.insysrx.com P: 480-500-3127

Description:

Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.

Key Statistics

Overview:

Market Capitalization, $K 21,707
Shares Outstanding, K 74,569
Annual Sales, $ 82,080 K
Annual Net Income, $ -124,510 K
Last Quarter Sales, $ 7,630 K
Last Quarter Net Income, $ -123,840 K
60-Month Beta 3.21
% of Insider Shareholders 65.40%
% of Institutional Shareholders 14.93%
Float, K 25,801
% Float 34.60%

Growth:

1-Year Return -96.25%
3-Year Return -97.69%
5-Year Return -98.14%
5-Year Revenue Growth -17.33%
5-Year Earnings Growth -339.66%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.55 on 05/13/19
Next Earnings Date 05/14/19
Earnings Per Share ttm -1.74
EPS Growth vs. Prev Qtr -48.72%
EPS Growth vs. Prev Year -163.64%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 2-1 on 06/08/15

INSY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1,430.37%
Return-on-Assets % -64.04%
Profit Margin % -151.69%
Debt/Equity 0.00
Price/Sales 0.27
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.16
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar